A proud milestone for Scinai Immunotherapeutics Ltd. and our partners at PinCell srl.
Heartfelt congratulations to Dr. Roberta Lotti of PinCell srl for receiving the “Oscar of Italian Dermatology” from SIDeMaST – Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse for her pioneering work on PC111, a novel anti-Fas Ligand antibody.
Her award-winning research confirms PC111’s non-immunosuppressive, disease-modifying potential in Pemphigus Vulgaris, reinforcing Scinai’s strategic option to acquire Pincell and advance this transformative therapy.
Amir Reichman , CEO of Scinai Immunotherapeutics Ltd. stated:
” 𝑇ℎ𝑖𝑠 𝑟𝑒𝑐𝑜𝑔𝑛𝑖𝑡𝑖𝑜𝑛 𝑟𝑒𝑖𝑛𝑓𝑜𝑟𝑐𝑒𝑠 𝑡ℎ𝑒 𝑠𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝑚𝑒𝑟𝑖𝑡 𝑜𝑓 𝑆𝑐𝑖𝑛𝑎𝑖’𝑠 𝑠𝑒𝑐𝑢𝑟𝑖𝑛𝑔 𝑎𝑛 𝑜𝑝𝑡𝑖𝑜𝑛 𝑡𝑜 𝑎𝑐𝑞𝑢𝑖𝑟𝑒 𝑃𝑖𝑛𝑐𝑒𝑙𝑙’𝑠 𝑎𝑢𝑡𝑜𝑖𝑚𝑚𝑢𝑛𝑒 𝑑𝑒𝑟𝑚𝑎𝑡𝑜𝑙𝑜𝑔𝑦 𝑝𝑖𝑝𝑒𝑙𝑖𝑛𝑒 𝑎𝑛𝑑 𝑣𝑎𝑙𝑖𝑑𝑎𝑡𝑒𝑠 𝑜𝑢𝑟 𝑐𝑜𝑛𝑣𝑖𝑐𝑡𝑖𝑜𝑛 𝑡ℎ𝑎𝑡 𝑃𝐶111 ℎ𝑎𝑠 𝑡ℎ𝑒 𝑝𝑜𝑡𝑒𝑛𝑡𝑖𝑎𝑙 𝑡𝑜 𝑏𝑒𝑐𝑜𝑚𝑒 𝑎 𝑡𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑣𝑒, 𝑑𝑖𝑠𝑒𝑎𝑠𝑒-𝑚𝑜𝑑𝑖𝑓𝑦𝑖𝑛𝑔 𝑡ℎ𝑒𝑟𝑎𝑝𝑦. 𝑊𝑒 𝑎𝑟𝑒 𝑐𝑜𝑛𝑓𝑖𝑑𝑒𝑛𝑡 𝑡ℎ𝑖𝑠 𝑝𝑟𝑜𝑔𝑟𝑎𝑚 𝑤𝑖𝑙𝑙 𝑑𝑒𝑙𝑖𝑣𝑒𝑟 𝑠𝑖𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑛𝑡 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑣𝑎𝑙𝑢𝑒 𝑡𝑜 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑎𝑛𝑑 𝑠𝑡𝑟𝑎𝑡𝑒𝑔𝑖𝑐 𝑣𝑎𝑙𝑢𝑒 𝑡𝑜 𝑜𝑢𝑟 𝑠ℎ𝑎𝑟𝑒ℎ𝑜𝑙𝑑𝑒𝑟𝑠”.
Congratulations Dr.Lotti, we’re proud to support science that can redefine treatment paradigms and improve patient outcomes.
Read the press release: https://lnkd.in/e3YhTydG
